Drugs / JEVAX-VABIOTECH-Vietnam
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03204227 Comparator | Jun → Aug 2017 | Japanese encephalitis | National Institute of Hygiene and Epidemiology, Vietnam | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JEVAX-VABIOTECH-Vietnam | “a licensed vaccine (JEVAX-VABIOTECH-Vietnam)” NCT03204227 ↗ |
| Known as | JEVAX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03204227 ↗ |
| Modality | Vaccine | “a licensed vaccine (JEVAX-VABIOTECH-Vietnam)” NCT03204227 ↗ |
| Route | Subcutaneous | “JEVAX - VABIOTECH Vietnam Liquid form Subcutaneous injection 0.5ml/dose, 2 doses, 28-34 days interval” NCT03204227 ↗ |